Insights › Science & technology › November 16, 2026
Science & technology · Pipeline & development

Cardiomyocytes in Persistent Cancer Therapy-related Cardiac Dysfunction Show Contractile and Natriuretic Peptide Signaling Signatures

bioRxiv (Pharmacology) Published: Preprint

BACKGROUND. Anthracycline and trastuzumab therapy of HER2-positive breast cancer causes cancer therapy-related cardiac dysfunction (CTRCD) in a subset of treated patients. Some recover cardiac function, others do not. Whether persistence is a cardiomyocyte-intrinsic property is unknown. OBJECTIVES. We sought to determine whether induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from

Original source
Read the source — biorxiv.org ↗

We link to the original publisher. The summary above is a short guide; read the original for the full details.

More in Science & technology

See everything in Science & technology →

Look into this further

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it all — start from $3No app-store installation. Cancel any time.